Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Cancers|March 10, 2022
Review of Therapeutic Strategies for Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung CancerTakafumi Fukui, Motoko Tachihara, Tatsuya Nagano, et al.
ACS Applied Materials & Interfaces|December 6, 2012
Ceramic thin films on plastics: a versatile transfer process for large area as well as patterned coatingHiromitsu Kozuka, Takafumi Fukui, Mitsuru Takahashi, et al.
Internal Medicine (Tokyo, Japan)|August 9, 2019
Impact of the Hospitalist System in Japan on the Quality of Care and Healthcare EconomicsOsamu Hamada, Takahiko Tsutsumi, Ayako Tsunemitsu, et al.
Cancer Science|August 25, 2018
Utility of the quasi-monomorphic variation range in unresectable metastatic colorectal cancer patientsHideaki Bando, Wataru Okamoto, Takafumi Fukui, et al.
International Journal of Molecular Sciences|June 24, 2022
Retrograde Axonal Transport of Liposomes from Peripheral Tissue to Spinal Cord and DRGs by Optimized Phospholipid and CTB ModificationTakafumi Fukui, Hironao Tateno, Takashi Nakamura, et al.
Breast Cancer (Tokyo, Japan)|July 24, 2021
TP53 signature diagnostic system using multiplex reverse transcription-polymerase chain reaction system enables prediction of prognosis of breast cancer patientsShin Takahashi, Takafumi Fukui, Tadashi Nomizu, et al.
Nagoya Journal of Medical Science|March 23, 2007
Suicide gene therapy using adenovirus vector for human oral squamous carcinoma cell line in vitroNoriyuki Yamamoto, Yasushi Hayashi, Hideaki Kagami, et al.
Thoracic Cancer|February 3, 2021
Malignant pleural mesothelioma in a patient with pneumothorax: A cumbersome subtype both clinically and pathologicallyTakafumi Fukui, Takako Okubo, Naoki Tanimoto, et al.
Oral Oncology|June 12, 2003
Improvement of transduction efficiency of recombinant adenovirus vector conjugated with cationic liposome for human oral squamous cell carcinoma cell linesHirokazu Fukuhara, Yasushi Hayashi, Noriyuki Yamamoto, et al.
Anticancer Research|August 28, 2025
Stratification by PD-L1 TPS in Advanced NSCLC With Low PD-L1 Expression for Optimizing ImmunotherapyTakafumi Fukui, Suya Hori, Yukihisa Hatakeyama, et al.
Pageof 4